Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	28.79	58.75	45.62
Graham Fair Price	-11.40	35.51	40.08
PEG	38.27	-1.02	-1.66
Price/Book	11.41	4.90	4.40
Price/Cash Flow	4.69	106.47	101.70
Prices/Earnings	41.88	21.67	15.27
Price/Sales	7.63	3.73	3.47
Price/FCF	4.69	106.47	101.70
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.03	0.36	0.35
Operating Margin	-26.22	0.06	0.07
ROA	-23.03	0.01	0.02
ROE	0.07	0.06	-21.48
ROIC	0.04	0.03	-22.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.15	-92.13
Dividends QOQ	< 0.005	< 0.005	122.30
EBIT QOQ	-0.10	-0.24	-136.24
EPS QOQ	-0.09	-0.21	-129.84
FCF QOQ	-0.60	0.06	-89.33
Revenue QOQ	-0.04	0.04	-13.62
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	115.59	114.92	-0.58
Days Sales Outstanding (DSO)	35.82	37.74	5.34
Inventory Turnover	0.78	0.78	0.58
Debt/Capitalization	0.47	0.47	-0.45
Quick Ratio	0.42	0.40	-5.34
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	31.49	31.48	-0.01
Cash	7.88	7.51	-4.80
Capex	-1.16	-0.83	28.98
Free Cash Flow	1.36	1.45	6.40
Revenue	39.97	41.36	3.49
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.23	1.14	-7.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.46	8.99	20.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating